RecruitingNCT05967949

A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.

Studying Primary cutaneous peripheral T-cell lymphoma not otherwise specified

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: The First Affiliated Hospital with Nanjing Medical University
Intervention: chidamide(drug)
Enrollment: 200 enrolled
Eligibility: 18 years · All sexes
Timeline: 2023 – 2028

Study locations (1)

Hematological Department, People's Hospital of Jiangsu Province, Nanjing, Jiangsu, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05967949 on ClinicalTrials.gov

← Back to all trials